SAMLYN CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CRVS)

Filing Manager
SAMLYN CAPITAL, LLC
Reporting Manager
Samlyn Capital, LLC
Security
Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
CRVS
Shares outstanding
68,031,684 shares
Disclosed Ownership
6,667,105 shares
Ownership
9.8%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 13:53:40 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samlyn Capital, LLC 9.8% 6,667,105 0 6,667,105 By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly/Managing Member*
Samlyn, LP 9.8% 6,667,105 0 6,667,105 By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly/Managing Member*
Robert Pohly 9.8% 6,667,105 0 6,667,105 By: /s/ Robert Pohly Robert Pohly*